Johnson & Johnson (JNJ) शेयर — क्या यह अच्छा व्यवसाय है?

Johnson & Johnson (JNJ) शेयर — क्या यह अच्छा व्यवसाय है? — InspectStocks

कमाई कैसे होती है

Innovative Medicine64%
MedTech36%

आमदनी के हिस्से six months ended June 28, 2026, high confidence के अनुमान हैं, किसी दाख़िल रिपोर्ट के आँकड़े नहीं।

मुकाबला किनसे है

क्या बेचती है6

DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.

3 और दिखाएँ

VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.

कौन खरीदता है4

Wholesalers, distributors and retailers that buy medicines and medical products for resale.
Hospitals and clinics that buy medicines and devices for patient care and procedures.
Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
Eye-care professionals and retailers that supply contact lenses and other vision products.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.

क्या ग़लत हो सकता है

1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.

पूरे वित्तीय विवरण →

Johnson & Johnson के बारे में

Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.

मुख्यालय: New Brunswick, New Jersey
स्थापना: 1887 (founding year, high confidence)
कर्मचारी: 140,800 (December 28, 2025, high confidence)
सूचीबद्ध: New York Stock Exchange
वित्त वर्ष का अंत: Last Sunday in December

Johnson & Johnson की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।

Keep exploring

The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The themes it is part of

Highest-graded in Drug Manufacturers General

Graded A or B and worth $2B or more: A first, then the largest.

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

कमाई कैसे होती है

Innovative Medicine64%
MedTech36%

मुकाबला किनसे है

क्या बेचती है6

DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.

3 और दिखाएँ

VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.

कौन खरीदता है4

Wholesalers, distributors and retailers that buy medicines and medical products for resale.
Hospitals and clinics that buy medicines and devices for patient care and procedures.
Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
Eye-care professionals and retailers that supply contact lenses and other vision products.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.

क्या ग़लत हो सकता है

1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.

पूरे वित्तीय विवरण →

Johnson & Johnson के बारे में

मुख्यालय: New Brunswick, New Jersey
स्थापना: 1887 (founding year, high confidence)
कर्मचारी: 140,800 (December 28, 2025, high confidence)
सूचीबद्ध: New York Stock Exchange
वित्त वर्ष का अंत: Last Sunday in December

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Johnson & Johnson के बारे में

Keep exploring

The themes it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Johnson & Johnson के बारे में

Keep exploring

The themes it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

Medical devices

Big pharma

Johnson & Johnson

वृद्धि और नकदी — 5 में से 5

कारोबार का रुझान

समय के साथ शेयर भाव और ग्रेड

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Johnson & Johnson के बारे में

Keep exploring

The themes it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Johnson & Johnson के बारे में

Keep exploring

The themes it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

Medical devices

Big pharma

Johnson & Johnson

पिछला प्रदर्शन

वृद्धि और नकदी — 5 में से 5

कारोबार का रुझान

समय के साथ शेयर भाव और ग्रेड